Moreover, traditional serum cancer biomarkers, such as carcinoembryonic antigen (CEA), carcinoembryonic antigen (CA72-4), and carbohydrate antigen 19-9 (CA19-9), have proven to be ineffective in screening for precancerous lesions of PLGC[66,67]. This evidence concerns the gene CEACAM5 and cancer.